Cellular Therapy & Immunobiology Working Party (CTIWP)
Study type:
Study number:
8420059
Type of treatment:
CAR T
Diseases:
All diseases
Short title:
CAR-T Cell access in Balkans
Primary objective:
To explore access to CAR-T cell therapy across the Balkan region. The survey aims to assess the availability and utilization of commercial and academic CAR-T therapies, identify major barriers to access, and explore healthcare system, regulatory, financial, and institutional factors influencing equitable access for eligible patients.
Key inclusion criteria:
All centers located in the Balkan region.
Country:
All EBMT member countries
Principal investigator:
Koray Yalcin
EBMT Study coordinator:
Jorinde Hoogenboom
EBMT Study Unit:
Leiden Study Unit
Reason for processing personal data:
Not applicable to surveys
Categories of personal data collected:
Not applicable to surveys
Recipients who may access the data:
Not applicable to surveys
3rd-party processors of Personal Data on behalf of EBMT/Service provider:
Not applicable to surveys
Privacy notices
Article 6 lawful basis for processing personal data:
Not applicable to surveys
Article 9 basis for processing special category data:
Not applicable to surveys
Data Protection Impact Assessments
Rights available to individuals:
Access
Data portability
Rectification
Objection
Deletion
Is a Data Protection Impact Assessment required?:
Not applicable to surveys
Retention Schedule (if possible):
Not applicable to surveys